China SXT Pharmaceuticals
SXTC
SXTC
3 hedge funds and large institutions have $35.5K invested in China SXT Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 5 closing their positions.
Holders
3
Holders Change
-5
Holders Change %
-62.5%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
UBS Group
Zurich,
Switzerland
| $25.4K | 6,408 | -23,462 | -79% |
|
2
Acadian Asset Management
Boston,
Massachusetts
| $10K | 2,759 | -102,280 | -97% |
|
3
Qube Research & Technologies (QRT)
London,
United Kingdom
| $12 | 3 | -47 | -94% |
|
4
Citadel Advisors
Miami,
Florida
| – | – | -191,339 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | – | -49,965 | Closed |
|
|
HF
6
HRT Financial
New York
| – | – | -48,507 | Closed |
|
|
LFAS
7
Level Four Advisory Services
Dallas,
Texas
| – | – | -42,771 | Closed |
|
|
BBA
8
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
| – | – | -12,916 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|